Willow Grove, PA, United States of America

Mehul F Patel

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 12 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Ab Sciex LLC, Watson Investor Communications, LLC. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mehul F Patel. Retrieved from https://idiyas.com/inventor/mehul-f-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 10)

Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 65(Granted Patents)

Location History:

Ambler, PA (US) (2011)
Waltham, MA (US) (2013)
Willow Grove, PA (US) (2013 - 2014)
Indianapolis, IN (US) (2016)
Blue Bell, PA (US) (2016 - 2019)

Company Filing History:

8 out of 2,405

Merck Sharp + Dohme Corp.

Watson Investor Communications, LLC

patents

Years Active: 2011-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels (2025-03-11),

2. 10189831 - Non-nucleoside reverse transcriptase inhibitors (2019-01-29),

3. 10004740 - Prodrugs of HIV reverse transcriptase inhibitors (2018-06-26),

4. 9718819 - Non-nucleoside reverse transcriptase inhibitors (2017-08-01),

5. 9417114 - System and method for dispensing a measured amount of a loose material (2016-08-16),

6. 9227971 - Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors (2016-01-05),

7. 8901142 - Fused tricyclic compounds as mTOR inhibitors (2014-12-02),

8. 8591943 - Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors (2013-11-26),

9. 8546404 - Compounds that are ERK inhibitors (2013-10-01),

10. 8021130 - Apparatus and method for handling fluids at nano-scale rates (2011-09-20),

11. 7897330 - Methods for characterizing enzyme inhibitors (2011-03-01),

Title: The Innovative Contributions of Mehul F Patel

Introduction

Mehul F Patel is a distinguished inventor based in Willow Grove, PA (US), known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Patel has made remarkable strides in developing compounds that address critical health issues.

Latest Patents

Among his latest patents, Patel has developed 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds that exhibit selective activity in voltage-gated sodium channels. These compounds are designed to inhibit Nav 1.7 ion channels found in peripheral and sympathetic neurons, offering potential treatments for pain disorders, cough, and itch. Additionally, he has created non-nucleoside reverse transcriptase inhibitors, which are compounds effective against HIV reverse transcriptase. These compounds are crucial for the prophylaxis and treatment of HIV infections and AIDS, showcasing Patel's commitment to advancing medical science.

Career Highlights

Throughout his career, Mehul F Patel has worked with prominent companies such as Merck Sharp & Dohme Corporation and Ab Sciex LLC. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Patel has collaborated with notable colleagues, including Yang Nan and M Arshad Siddiqui, further enhancing the impact of his work through teamwork and shared knowledge.

Conclusion

Mehul F Patel's innovative work in developing pharmaceutical compounds has made a significant impact on healthcare. His dedication to addressing complex medical challenges through his patents exemplifies the spirit of innovation in the field.

Profile summary based on public USPTO records.